[HTML][HTML] Bone marrow CD34+ molecular chimerism as an early predictor of relapse after allogeneic stem cell transplantation in patients with acute myeloid leukemia
M Malagola, N Polverelli, A Beghin, F Bolda… - Frontiers in …, 2023 - frontiersin.org
Background: minimal residual disease (MRD) monitoring is an important tool to optimally
address post-transplant management of acute myeloid leukemia (AML) patients. Methods …
address post-transplant management of acute myeloid leukemia (AML) patients. Methods …
A novel flow-cytometric based method to assess post-HSCT donor chimerism exploiting RNA hybridization
S Nucera, MM Sindoni, C Bugarin, T Villa… - Bone Marrow …, 2024 - nature.com
Abstract Analysis of donor-recipient chimerism after hematopoietic stem cell transplantation
(HSCT) is of pivotal importance for patient's clinical management, especially in the context of …
(HSCT) is of pivotal importance for patient's clinical management, especially in the context of …